首頁
Square Pharmaceuticals

11月 2025Square Pharmaceuticals的市場佔有率分析

Square Pharmaceuticals Ltd. is a Bangladeshi multinational pharmaceutical company. It was founded in 1958 by Samson H. Chowdhury along with three of his friends PK Saha, Kazi Harunur Roshid and Radhabinod Rai as a private firm.

健康 > 藥房

域名squarepharma.com.bd

成立年份1958

僱員> 10001

年度營收$500M - $1B

Square Pharmaceuticals

Square Pharmaceuticals（包含公司地區）

squarepharma.com.bd

查看更多網站流量與參與度資訊

Square Pharmaceuticals截至 11月 2025 的總收入為 500M - 1B

Square Pharmaceuticals 熱門網域產生的總收入

Square Pharmaceuticals 熱門網域 3 年內的總收入

Square Pharmaceuticals 熱門網域的總收入

squarepharma.com.bd500M - 1B

透過銷售情報查看更多內容

Square Pharmaceuticals的熱門網域總造訪量

了解Square Pharmaceuticals市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

squarepharma.com.bd118.3K

透過銷售情報查看更多內容

Square Pharmaceuticals的熱門網域平均造訪時長

分析Square Pharmaceuticals參與度指標。

過去 3 個月平均造訪時長

子公司細目

squarepharma.com.bd00:02:24

透過銷售情報查看更多內容

Square Pharmaceuticals的熱門網域平均頁面瀏覽量

了解Square Pharmaceuticals如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

squarepharma.com.bd3.19

透過銷售情報查看更多內容

Square Pharmaceuticals按網域劃分的熱門競爭對手

11月 2025的熱門類似網站，依相似度排名

inceptapharma.com公司名Incepta Pharmaceuticals僱員5001 - 10000總部孟加拉國, Dhaka年度營收$200M - $500M訪問總量27.5K健康 > 藥房

使用的熱門技術Square Pharmaceuticals

这些是Square Pharmaceuticals顶级域名使用的行业网站技术

付款與貨幣 (22)

Cart Functionality

小工具 (5)

reCAPTCHA

付費廣告 (3)

PubMatic

社群 (3)

Facebook Connect

更多技術

8

檢視所有

新聞與訊號來自Square Pharmaceuticals

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Boehringer Ingelheim partners with Square Pharmaceuticals Ltd..Boehringer Ingelheim, a global leader in animal health, has joined hands with Square Pharmaceuticals PLC to introduce Aftovaxpur, an advanced FMD vaccine for ruminants in Bangladesh.

新聞Square Pharmaceuticals Ltd. partnered with Aristopharma Ltd. on Jul 31st '23.Earlier last week, Square Pharma entered into a separate outsourcing agreement with Aristopharma Ltd

新聞Square Pharmaceuticals Ltd. invests into assets: facilities in the amount of $20M in Nairobi, Kenya.Square has already invested $20 million to build the facilities near Nairobi aiming for a stronger presence in the African drugs market and the Kenyan media reported that the investment might go up in phases.